BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,952 Cr | ₹-180 Cr | ₹3,823 Cr | ₹4,554 Cr | ₹3,390 Cr |
What is the latest Net Current Assets ratio of BIOCON ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹1,952 Cr |
| Mar2024 | ₹-180 Cr |
| Mar2023 | ₹3,823 Cr |
| Mar2022 | ₹4,554 Cr |
| Mar2021 | ₹3,390 Cr |
How is Net Current Assets of BIOCON Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,952 Cr | Positive | |
| Mar2024 | ₹-180 Cr | Negative | |
| Mar2023 | ₹3,823 Cr | -16.05 | |
| Mar2022 | ₹4,554 Cr | 34.33 | |
| Mar2021 | ₹3,390 Cr | - | |
Compare Net Current Assets of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹59,187.2 Cr | -1.1% | -7.3% | 3.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,713.0 Cr | -1.4% | -3.2% | -0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,811.0 Cr | -1.9% | -8.7% | 1.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,052.0 Cr | -3.5% | -6.6% | 30.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,927.0 Cr | -4% | -8.3% | 6.3% | Stock Analytics | |
| CIPLA | ₹96,602.7 Cr | -1.9% | -11.9% | -19% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -1.1% |
-7.3% |
3.7% |
| SENSEX | 0.6% |
-11.1% |
-6.2% |
You may also like the below Video Courses